The company is one of the fastest-growing pharmaceutical companies in the world, and has been working on a product that can be used to treat diseases like cancer and Alzheimer’s, reports Forbes.

But Madrigals patented process, which uses a unique process called “bio-hacking,” has a huge potential to be used for other diseases.

Madrigal said it has been studying the process since 2010 and has worked closely with research scientists around the world.

The process involves combining the patient’s DNA with the body’s own.

In a lab setting, the patient receives a cocktail of drugs, including chemotherapy and radiotherapy, which then interact with cells and tissue to produce the desired result.

Madriaga said it hopes to use the process to help treat diseases such as cancer, diabetes and multiple sclerosis, among others.

“The technology that we are working on now is one that has been around for a long time, but now it has this next step to it,” Madriga said.

“And we are not just talking about the next generation of medicines, we are talking about regenerative therapies that can treat diseases and even the diseases that we see in humans, or that we think are disease-causing.”

Madrigas scientists are looking to take the technology to patients with severe diseases such a HIV infection, and are looking at how to help patients with more serious diseases, like Alzheimer’s and cancer.

In addition to working on therapies for cancer, Madrigas is also working on regenerative diabetes, which will allow the treatment to be administered in a patient’s own body.

Madrigalia said it would be “very important” to continue its work in that area, and will work with pharmaceutical companies to develop the technology.

It’s not the first time Madrigallos has been using the process for regenerative medicines.

In 2013, the company released a new type of insulin, which is currently being studied in a lab, that is also being used for regenerating tissues.

The company’s next steps include exploring the use of the process in regenerative heart disease treatment.